[Retracted] Expression of miR-210, miR-137, and miR-153 in Patients with Acute Cerebral Infarction

Table 2

Clinical data of patients.

Factors	Observation group ()	Control group ()	value	value
Gender
Male	45 (59.21)	42 (65.63)	0.608	0.436
Female	31 (40.79)	22 (34.38)
Age			0.561	0.576
BMI (kg/m^2)			1.216	0.226
Past medical history
Hypertension	19 (25.00)	21 (32.81)	1.039	0.308
Diabetes	13 (17.11)	10 (15.63)	0.055	0.814
Hyperlipidemia	8 (10.53)	8 (12.50)	0.134	0.715
History of smoking
Yes	19 (25.00)	18 (28.13)	0.175	0.676
No	57 (75.00)	46 (71.88)
History of alcohol abuse
Yes	9 (11.84)	10 (15.63)	0.424	0.515
No	67 (88.16)	54 (84.38)
Place of residence
City	58 (76.32)	50 (78.13)	0.065	0.800
Rural	18 (23.68)	14 (21.88)
Platelet count (×10^9/L)			0.632	0.528
Total cholesterol (mmol/L)			0.782	0.277
Triglyceride (mmol/L)			1.144	0.255
Location of infarction
Frontal lobe	12 (15.79)
Temporal lobe	10 (13.16)
Parietal lobe	9 (11.84)
Occipital lobe	9 (11.84)
Basal ganglia	10 (13.16)
Thalamus	11 (14.47)
Cerebellum	10 (13.16)
Brainstem	5 (6.58)
Infarct size
Lacunar infarction	39 (51.32)
Medium area infarction	23 (30.26)
Massive infarction	14 (18.42)